Literature DB >> 26987417

Personality in multiple sclerosis (MS): impact on health, psychological well-being, coping, and overall quality of life.

L B Strober1,2.   

Abstract

Personality has long been considered a factor that can account for differences in health, well-being, and overall quality of life (QOL). A 'Distressed or Type D Personality' has been studied in medical populations as a predictor of several outcomes. The purpose of the present investigation was to determine the presence of Type D Personality in multiple sclerosis (MS) and its role on disease symptoms, disease management, health-related behaviors, coping, psychological well-being, and overall QOL and functioning. Two hundred and thirty (230) individuals with MS completed a survey assessing personality, disease symptoms, disease management, coping, self-efficacy, locus of control (LOC), psychological well-being, and QOL. Thirty-seven (16%) individuals were found to be 'Type D+.' Such individuals reported greater fatigue, pain, depression, and anxiety and worse disease management and adherence. They also reported engaging in maladaptive means of coping. Compared to 'Type D-' they reported lower self-efficacy, LOC, QOL and greater perceived stress. Finally, 'Type D+' individuals were more likely to be considering leaving the workforce. Findings suggest that 'Type D' Personality is associated with various negative outcomes in MS. Consideration of the routine assessment of personality in MS seems warranted and may better inform interventions and ward off poor outcomes.

Entities:  

Keywords:  Multiple sclerosis; coping; health; personality

Mesh:

Year:  2016        PMID: 26987417      PMCID: PMC5214537          DOI: 10.1080/13548506.2016.1164321

Source DB:  PubMed          Journal:  Psychol Health Med        ISSN: 1354-8506            Impact factor:   2.423


  34 in total

1.  Type D (distressed) personality is associated with poor quality of life and mental health among 3080 cancer survivors.

Authors:  Floortje Mols; Melissa S Y Thong; Lonneke V van de Poll-Franse; Jan Anne Roukema; Johan Denollet
Journal:  J Affect Disord       Date:  2011-09-23       Impact factor: 4.839

Review 2.  Type D personality as a prognostic factor in heart disease: assessment and mediating mechanisms.

Authors:  Nina Kupper; Johan Denollet
Journal:  J Pers Assess       Date:  2007-12

3.  Personality disorder in multiple sclerosis correlates with cognitive impairment.

Authors:  R H Benedict; R L Priore; C Miller; F Munschauer; L Jacobs
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2001       Impact factor: 2.198

4.  Type D, anxiety and depression in association with quality of life in patients with Parkinson's disease and patients with multiple sclerosis.

Authors:  Tatiana Dubayova; Martina Krokavcova; Iveta Nagyova; Jaroslav Rosenberger; Zuzana Gdovinova; Berrie Middel; Johan W Groothoff; Jitse P van Dijk
Journal:  Qual Life Res       Date:  2012-10-11       Impact factor: 4.147

5.  A global measure of perceived stress.

Authors:  S Cohen; T Kamarck; R Mermelstein
Journal:  J Health Soc Behav       Date:  1983-12

6.  Cytokines and immune activation in systolic heart failure: the role of Type D personality.

Authors:  Johan Denollet; Viviane M Conraads; Dirk L Brutsaert; Luc S De Clerck; Wim J Stevens; Christiaan J Vrints
Journal:  Brain Behav Immun       Date:  2003-08       Impact factor: 7.217

7.  Measuring the functional impact of fatigue: initial validation of the fatigue impact scale.

Authors:  J D Fisk; P G Ritvo; L Ross; D A Haase; T J Marrie; W F Schlech
Journal:  Clin Infect Dis       Date:  1994-01       Impact factor: 9.079

8.  Personality and mortality after myocardial infarction.

Authors:  J Denollet; S U Sys; D L Brutsaert
Journal:  Psychosom Med       Date:  1995 Nov-Dec       Impact factor: 4.312

9.  Type D personality and quality of life in patients with irritable bowel syndrome.

Authors:  Reza Bagherian Sararoudi; Hamid Afshar; Peyman Adibi; Hamed Daghaghzadeh; Jaleh Fallah; Farzaneh Abotalebian
Journal:  J Res Med Sci       Date:  2011-08       Impact factor: 1.852

10.  Conscientiousness, career success, and longevity: a lifespan analysis.

Authors:  Margaret L Kern; Howard S Friedman; Leslie R Martin; Chandra A Reynolds; Gloria Luong
Journal:  Ann Behav Med       Date:  2009-05-20
View more
  11 in total

1.  White matter tract network disruption explains reduced conscientiousness in multiple sclerosis.

Authors:  Tom A Fuchs; Michael G Dwyer; Amy Kuceyeski; Sanjeevani Choudhery; Keith Carolus; Xian Li; Matthew Mallory; Bianca Weinstock-Guttman; Dejan Jakimovski; Deepa Ramasamy; Robert Zivadinov; Ralph H B Benedict
Journal:  Hum Brain Mapp       Date:  2018-05-08       Impact factor: 5.038

2.  The Big Five Personality Traits and Positive Orientation in Polish Adults with Multiple Sclerosis: The Role of Meaning in Life.

Authors:  Małgorzata Szcześniak; Andrzej Potemkowski; Waldemar Brola; Zdzisław Kroplewski; Roman Ryszard Szałachowski; Marek Zak; Maciej Wilski; Piotr Sobolewski; Halina Bartosik-Psujek; Katarzyna Kapica-Topczewska; Joanna Tarasiuk; Agata Czarnowska; Alina Kułakowska; Beata Zakrzewska-Pniewska; Katarzyna Kubicka-Bączyk; Natalia Morawiec; Monika Adamczyk-Sowa; Adam Stępień; Jacek Zaborski; Anna Ratajczak; Marcin Ratajczak
Journal:  Int J Environ Res Public Health       Date:  2022-04-29       Impact factor: 4.614

3.  Quality of life and psychological well-being in the early stages of multiple sclerosis (MS): Importance of adopting a biopsychosocial model.

Authors:  L B Strober
Journal:  Disabil Health J       Date:  2018-05-31       Impact factor: 2.554

4.  Lifestyle, medication and socio-demographic determinants of mental and physical health-related quality of life in people with multiple sclerosis.

Authors:  George A Jelinek; Alysha M De Livera; Claudia H Marck; Chelsea R Brown; Sandra L Neate; Keryn L Taylor; Tracey J Weiland
Journal:  BMC Neurol       Date:  2016-11-22       Impact factor: 2.474

5.  Cognitive-constructivist Approach in Medical Settings: The Use of Personal Meaning Questionnaire for Neurological Patients' Personality Investigation.

Authors:  Barbara Poletti; Laura Carelli; Annalisa Lafronza; Federica Solca; Andrea Faini; Andrea Ciammola; Monica Grobberio; Vanessa Raimondi; Rita Pezzati; Rita B Ardito; Vincenzo Silani
Journal:  Front Psychol       Date:  2017-04-11

6.  Adverse childhood experiences predict reaction to multiple sclerosis diagnosis.

Authors:  Tehila Eilam-Stock; Jon Links; Nabil Z Khan; Tamar E Bacon; Guadalupe Zuniga; Lisa Laing; Carrie Sammarco; Kathleen Sherman; Leigh Charvet
Journal:  Health Psychol Open       Date:  2021-10-21

7.  Effect of Mindfulness Meditation on Personality and Psychological Well-being in Patients with Multiple Sclerosis.

Authors:  Cristiano Crescentini; Alessio Matiz; Matteo Cimenti; Eric Pascoli; Roberto Eleopra; Franco Fabbro
Journal:  Int J MS Care       Date:  2018 May-Jun

8.  Health-related outcomes, health care resource utilization, and costs of multiple sclerosis in Japan compared with US and five EU countries.

Authors:  Kaoru Yamabe; Marco D DiBonaventura; Chris L Pashos
Journal:  Clinicoecon Outcomes Res       Date:  2019-01-07

9.  Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis.

Authors:  Alberto Gajofatto; Valeria Donisi; Isolde Martina Busch; Francesca Gobbin; Elena Butturini; Massimiliano Calabrese; Alessandra Carcereri de Prati; Paola Cesari; Lidia Del Piccolo; Massimo Donadelli; Paolo Fabene; Stefania Fochi; Macarena Gomez-Lira; Roberta Magliozzi; Giovanni Malerba; Raffaella Mariotti; Sofia Mariotto; Chiara Milanese; Maria Grazia Romanelli; Andrea Sbarbati; Federico Schena; Maria Angela Mazzi; Michela Rimondini
Journal:  BMJ Open       Date:  2019-08-02       Impact factor: 2.692

10.  Information-Seeking Strategies of People with Multiple Sclerosis in Spain: The INFOSEEK-MS Study.

Authors:  Yolanda Higueras; Elisa Salas; Virginia Meca-Lallana; Pedro Carrascal Rueda; Ofir Rodríguez De la Fuente; Rosana Cabello-Moruno; Jorge Maurino; Miguel Ángel Ruiz Díaz
Journal:  Patient Prefer Adherence       Date:  2022-01-11       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.